Clinical Trial Update: Angiotensin 1-7 in Obesity Hypertension [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 study evaluating Angiotensin 1-7 for obesity and hypertension has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Obesity

Drugs mentioned

• Angiotensin-(1-7) (Angiotensin-(1-7))

Snippet

Sponsor: Amy Arnold | Conditions: Obesity, Hypertension | EARLY_Phase 1 | Status: TERMINATED